These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18558358)

  • 1. What is the contents of the magic draft IVIg?
    Seite JF; Shoenfeld Y; Youinou P; Hillion S
    Autoimmun Rev; 2008 Jun; 7(6):435-9. PubMed ID: 18558358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
    Rossi F; Kazatchkine MD
    J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.
    Schaub A; von Gunten S; Vogel M; Wymann S; Rüegsegger M; Stadler BM; Spycher M; Simon HU; Miescher S
    Allergy; 2011 Aug; 66(8):1030-7. PubMed ID: 21385183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.
    Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y
    J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used.
    Djoumerska I; Tchorbanov A; Pashov A; Vassilev T
    Scand J Immunol; 2005 Apr; 61(4):357-63. PubMed ID: 15853919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled human immunoglobulins contain anti-idiotypes with reactivity against the SLE-associated 4B4 cross-reactive idiotype.
    DeKeyser F; DeKeyser H; Kazatchkine MD; Rossi F; Dang H; Talal N
    Clin Exp Rheumatol; 1996; 14(6):587-91. PubMed ID: 8978951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
    Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations.
    Altznauer F; von Gunten S; Späth P; Simon HU
    J Allergy Clin Immunol; 2003 Dec; 112(6):1185-90. PubMed ID: 14657880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies.
    Vassilev TL; Bineva IL; Dietrich G; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1995 Jun; 8(3):405-13. PubMed ID: 7576001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations.
    Bussone G; Dib H; Dimitrov JD; Camoin L; Broussard C; Tamas N; Guillevin L; Kaveri SV; Mouthon L
    Proteomics; 2009 Apr; 9(8):2253-62. PubMed ID: 19296548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
    Kaneko Y; Nimmerjahn F; Ravetch JV
    Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of natural antibodies in immune homeostasis: IVIg perspective.
    Vani J; Elluru S; Negi VS; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Autoimmun Rev; 2008 Jun; 7(6):440-4. PubMed ID: 18558359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins.
    Bouhlal H; Martinvalet D; Teillaud JL; Fridman C; Kazatchkine MD; Bayry J; Lacroix-Desmazes S; Kaveri SV
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S4-11. PubMed ID: 24682714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg).
    Ronda N; Haury M; Nobrega A; Coutinho A; Kazatchkine MD
    Clin Immunol Immunopathol; 1994 Feb; 70(2):124-8. PubMed ID: 8299227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
    Anumula KR
    J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural human antibodies to amyloid beta peptide.
    Szabo P; Relkin N; Weksler ME
    Autoimmun Rev; 2008 Jun; 7(6):415-20. PubMed ID: 18558354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.